Get insights on the upcoming HOPE 3 phase 3 trial, key endpoints, and investment risks for CAPR. Learn what to watch in ...

As health-care workers around the world will attest, infections are extremely common in children in primary care and ...

Researchers at the Icahn School of Medicine at Mount Sinai in New York, Boston Medical Center, and Boston University ...

A new pooled analysis of the FIBRONEER™-IPF and FIBRONEER™-ILD trials resulted in a nominally significant reduction in the risk of death by 59% ...

Researchers at the Icahn School of Medicine at Mount Sinai in New York, Boston Medical Center, and Boston University ...

Dr. Sutera opened his talk by outlining that he would divide his presentation into three parts: first, defining MMAI; second, discussing its application in oligometastatic prostate cancer; and third, ...

(UroToday.com) The 2025 ASTRO annual meeting featured a biomarker breakthroughs prostate cancer session and a discussant presentation by Dr. Alan Dal Pra. Dr. Dal Pra noted that amongst the six ...

Aim To identify subgroups of early rheumatoid arthritis (RA) based on comorbidities and RA manifestations and to investigate ...

The Paediatric Committee (PDCO) of the European Medicines Agency issued a positive opinion on Acurx's Pediatric Investigation Plan (PIP) for ibezapolstat ...

Leadership Development Programs, Future Managers, Sierra Leone, Strategic Competence, Digital Skills, Curriculum Evaluation, ...

Learn how to master Excel for data analysis and uncover actionable insights with this step-by-step guide. Perfect for beginners and pros ...

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that eight poster presentations highlighting new research in amyotrophic lateral sclerosis (ALS) will be shared at the Northeast ...